Pietro Campiglia Selected Research

Pietro Campiglia Research Topics

Disease

31	Neoplasms (Cancer) 06/2022 - 02/2005
9	Breast Neoplasms (Breast Cancer) 05/2020 - 02/2005
7	Inflammation (Inflammations) 01/2022 - 01/2017
7	Infections 12/2021 - 01/2013
6	Hypertension (High Blood Pressure) 01/2022 - 11/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2011
3	COVID-19 08/2022 - 08/2021
3	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 06/2011
3	Carcinogenesis 01/2022 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 12/2020
3	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 06/2010
3	Colitis 01/2020 - 01/2018
3	Heart Failure 12/2019 - 11/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2017
3	Melanoma (Melanoma, Malignant) 07/2016 - 05/2008
3	Hypertrophy 11/2015 - 11/2013
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 05/2008
3	Carcinoma (Carcinomatosis) 06/2010 - 02/2005
2	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 12/2021
2	Ulcerative Colitis 01/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 08/2021
2	Human Influenza (Influenza) 09/2021 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2016
2	Hyperalgesia 10/2020 - 07/2018
2	Non-alcoholic Fatty Liver Disease 05/2020 - 11/2017
2	Adenocarcinoma 05/2020 - 05/2008
2	Necrosis 02/2020 - 01/2016
2	Wounds and Injuries (Trauma) 01/2020 - 12/2019
2	Pain (Aches) 11/2019 - 07/2018
2	Insulin Resistance 03/2019 - 12/2009
2	Atherosclerosis 01/2017 - 03/2014
2	Cardiomegaly (Heart Hypertrophy) 11/2015 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 12/2009
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2022
1	Parotid Neoplasms 06/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Glioma (Gliomas) 01/2022

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 09/2021 - 09/2009
8	Pharmaceutical PreparationsIBA 12/2021 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 07/2011
5	Phosphotransferases (Kinase)IBA 11/2020 - 03/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 02/2005
4	LipidsIBA 08/2022 - 03/2017
4	Annexin A1IBA 10/2021 - 01/2020
4	AntioxidantsIBA 05/2020 - 01/2015
4	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2017 - 03/2010
3	Antineoplastic Agents (Antineoplastics)IBA 08/2022 - 06/2010
3	EnzymesIBA 04/2022 - 01/2013
3	Biological ProductsIBA 12/2021 - 10/2012
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 05/2008
3	PolyphenolsIBA 08/2020 - 12/2013
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 10/2016
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 02/2015 - 03/2010
2	AndrogensIBA 08/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2022
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 05/2022 - 01/2017
2	AcidsIBA 01/2022 - 07/2011
2	CalciumIBA 12/2021 - 02/2015
2	QuercetinIBA 08/2021 - 10/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2013
2	Annexin A4IBA 01/2021 - 05/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2016
2	G-Protein-Coupled Receptor Kinase 2IBA 11/2020 - 12/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 07/2018
2	icilinIBA 10/2020 - 07/2018
2	CytokinesIBA 03/2019 - 01/2018
2	Insulin (Novolin)FDA Link 03/2019 - 12/2009
2	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 11/2017
2	CholesterolIBA 01/2019 - 05/2017
2	LactoferrinIBA 10/2018 - 01/2017
2	Protein Tyrosine PhosphatasesIBA 01/2018 - 10/2012
2	Pen(5)-Trp(7)-Orn(8)- urotensin II (4-11)IBA 03/2014 - 07/2009
2	ResveratrolIBA 12/2013 - 09/2013
2	SolutionsIBA 11/2013 - 10/2012
2	indolineIBA 07/2013 - 12/2010
2	(3,3')spiro((hexahydropyrrolo(1,2- a)pyrazine- 1,4- dione)- 6,3'- (2',3'- dihydrothieno(2,3- b)naphtho- 4',9'- dione))IBA 01/2013 - 06/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 06/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 07/2011
2	Cisplatin (Platino)FDA LinkGeneric 04/2007 - 02/2005
1	Triglycerides (Triacylglycerol)IBA 06/2022
1	NucleotidesIBA 06/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 06/2022
1	SphingomyelinsIBA 06/2022
1	Angiotensin-Converting Enzyme 2IBA 05/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	NADPH Oxidase 2IBA 01/2022
1	antiglomerular basement membrane antibodyIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	InterleukinsIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022

Therapy/Procedure

13	Therapeutics 08/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
1	Castration 08/2022
1	Lasers (Laser) 06/2022